entity

Treatment Response

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Treatment Response: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

8Connections

1Hypotheses

2Analyses

1Outgoing

7Incoming

0Experiments

3Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibitor Response

experiment · 1020 words

→

Mixed Pathology Effects on Parkinson's Disease Progression and Treatment Response

experiment · 687 words

→

Outgoing (1)

Target	Relation	Type	Str
Clonal Evolution	associated_with	process	0.80

Incoming (7)

Source	Relation	Type	Str
DELFI-TF	biomarker_for	biomarker	0.90
NfL	biomarker_for	biomarker	0.90
Gene Expression Profiles	associated_with	biomarker	0.85
Dominant Immune Modules	correlates_with	biomarker	0.80
Tumor Immune Microenvironment	involved_in	process	0.75
NPM1 Mutations	associated_with	biomarker	0.75
plasma p-tau217	biomarker_for	biomarker	0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Multi-Biomarker Composite Index Surpassing Amyloid PET for T	0.579	neurodegeneration	Multi-modal Biomarker Panel Design for E

Mentioning Analyses (2)

Scientific analyses that reference this entity

What amyloid threshold level is required for optimal clinical benefit in early A

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.577

Which metabolic biomarkers can distinguish therapeutic response from disease pro

translational neuroscience | 2026-04-04 | 2 hypotheses Top: 0.532

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (6)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567]	Guerreiro S, Privat AL, Bressac L, Toulo	Cells	2020
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
CD38 in Neurodegeneration and Neuroinflammation. [PMID:32085567]	Guerreiro S, Privat AL, Bressac L, Toulo	Cells	2020
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020

Debates (3)

Multi-agent debates referencing this entity

Hypothesis debate: Multi-Biomarker Composite Index Surpassing Amyloid PET for Tr

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

While the study demonstrates dose-response relationships between amyloid levels

closed · Rounds: 4 · Score: 0.76 · 2026-04-16

Which metabolic biomarkers can distinguish therapeutic response from disease pro

closed · Rounds: 4 · Score: 0.77 · 2026-04-12

Related Research

Hypotheses and analyses mentioning Treatment Response in their description or question text

No additional research found